| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly has made significant strides in product development, particularly in the area of non-addictive pain management solutions, exemplified by their acquisition of 4E Therapeutics. The successful release of innovative products, such as Mounjaro and Zepbound, underscores their commitment to addressing critical health concerns like obesity. This innovation not only propels the company towards high market valuation but also positions it as a leader in the pharmaceutical sector. However, competition from other pharmaceutical companies, especially in the obesity treatment landscape, continues to pose challenges. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.3 is modestly bearish. The market sentiment at 0.5 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.1 on 2026-06-22. The forces of Sector Price Trend (-0.5), Valuation Sentiment (-0.3), and Stock Price Trend (-0.3) will drive down the price. The forces of Price Level Sentiment (0), Market Risk Appetite (0.1), Option Sentiment (0.8), and Sentiment towards Fundamentals (2.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 | 0%(0%) | 1104.03 | 2.59% | 44 | 55 | 59 | 0.54% | -0.26% | -0.3 | 0.2 | 0.4% | 0.4 | Long | 55% | 2.5 | 5.5 |
| 2026-06-21 | 0%(0%) | -0.4 | 0.2 | -0.2 | 2 | -1 | ||||||||||
| 2026-06-20 | 0%(0%) | -0.4 | 0.2 | -0.1 | 2.5 | -1 | ||||||||||
| 2026-06-19 | 0%(0%) | -0.4 | 0.2 | -0.1 | 2.7 | -1 | ||||||||||
| 2026-06-18 | 0%(0%) | 1098.13 | 2.95% | 42 | 48 | 28 | -1.24% | -0.24% | -0.4 | -0.1 | 0.6% | -0.2 | Short | 55% | 2.5 | 7 |
| 2026-06-17 | 0%(0%) | 1111.89 | 3.4% | 55 | 47 | 26 | -0.95% | 0.26% | 0.5 | -0.3 | 0.7% | -0 | Wait | 50% | 2.8 | -1 |
| 2026-06-16 | 0%(0%) | 1122.57 | 3.73% | 64 | 57 | 56 | -0.62% | 0.51% | 0.9 | -0.2 | 0.7% | 0.5 | Wait | 50% | 3.6 | 2.7 |
| 2026-06-15 | 0%(0%) | 1129.59 | 4.25% | 69 | 61 | 27 | -0.3% | 0.43% | 0.9 | -0.3 | 1.4% | 0.5 | Wait | 50% | 3.9 | 1 |
| 2026-06-14 | 0%(0.1%) | 0.8 | -0.3 | 0.4 | 4.6 | 7 | ||||||||||
| 2026-06-13 | 0%(0.1%) | 0.8 | -0.3 | 0.4 | 4.5 | -1 | ||||||||||
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-06-22 17:01:46 The articles indicate a focus on how Eli Lilly is positioning itself in the market relative to its competitors. |
| 2026-06-22 17:01:46 The comparison of quarterly results between Eli Lilly and Pfizer suggests significant financial developments for investors. |
| 2026-06-22 17:01:46 The competition between Eli Lilly and Pfizer highlights the differing strategies and market positions in the obesity treatment sector. |
| 2026-06-22 17:01:46 Eli Lilly has announced dividends, which reflects positively on its financial health and shareholder commitment. |
| 2026-06-22 17:01:46 The articles discuss Eli Lilly’s stock performance, indicating a positive trend. |
| 2026-06-22 13:48:13 The boom and bust cycles of the pharmaceutical industry raise concerns about long-term stability for Eli Lilly's market cap. |
| 2026-06-22 13:48:13 Eli Lilly's development of innovative drugs like Mounjaro and Zepbound has been crucial in their rise to a $1 trillion market value. |
| 2026-06-22 13:48:13 The guidance of CEO Dave Ricks is pivotal in steering the company's growth and navigating the complexities of the pharmaceutical market. |
| 2026-06-22 13:48:13 The ongoing competition in the pharmaceutical industry presents challenges for Eli Lilly, particularly as it looks to maintain its market position. |
| 2026-06-22 13:48:13 Eli Lilly's transformation into a trillion-dollar company signifies significant growth and profitability, particularly in the pharmaceutical industry. |